The discrepancy is too large to be dismissed as a chance finding, suggest the researchers, but could be the result of publication biassome studies might have been prioritized for publication because of the positive nature of their results whereas the unpublished datasets used in this study would not have been affected by any failure to publish null results
Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis
*This guide is for educational purposes
GLP-1 receptor agonists Including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are peptide-based drugs that have completed full FDA review and carry approved indications for type 2 diabetes and obesity
Getting onto it isn't an approval
Ansari WA, Ahamad T, Khan MA, Khan ZA, Khan MF